MiNA Therapeutics Denmark ApS
CVR 43329545 · Private limited company (ApS) · Dissolved by declaration
MiNA Therapeutics Denmark ApS is a Private limited company (ApS), founded on , based in København SV. The company is registered in the industry fremstilling af farmaceutiske præparater. The company is no longer active (status: dissolved by declaration). 3 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2024) shows equity of DKK 1.3m and a net result of DKK 373k.
Company details
- CVR number
- 43329545
- Status
- Dissolved by declaration
- Company type
- Private limited company (ApS)
- Founded
- Ceased
- Address
- c/o University of Aalborg, Frederikskaj 10B, 2.
2450 København SV - Municipality
- København
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 40k
- Auditor
- Boreco
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 3 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 21.1% |
| Current ratio | 331% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 3 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 2 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2024 | 2023 |
|---|---|---|
| Gross profit | DKK 4.7m | DKK 11.3m |
| Net profit | DKK 373k | DKK 6.6m |
| Equity | DKK 1.3m | DKK 911k |
| Total assets | DKK 6.1m | DKK 2.1m |
| Cash | DKK 359k | – |
| Short-term debt | DKK 1.8m | – |
| Tax owed | DKK 114k | – |
| Avg. employees | 2 | – |
Latest annual report: Reporting class B · auditor's statement: Erklæring om udvidet gennemgang · Boreco.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2024 – 31 Dec 2024 | 185 | Late | |
| 1 Jan 2023 – 31 Dec 2023 | 173 | ||
| 15 Jun 2022 – 31 Dec 2022 | 181 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Troels Koch | ||
| CEO | Robert Sebastian Habib | ||
| CEO | Nagy Adly Habib | ||
| CEO | Peter James Jonathan Bains | ||
| CEO | Robin James Morrisson Wright | ||
| Board | Gur-Arye Yehuda Roshwalb | ||
| Board | Robert Sebastian Habib | ||
| Board | Nagy Adly Habib | ||
| Board | Peter James Jonathan Bains | ||
| Board | Kieran Roy Darren Johnson | ||
| Board | Robert Charles Kopple | ||
| Board | Christopher Barry Wood | ||
| Board | Robert Ian Lechler | ||
| Board | Susan Clement Davies | ||
| Board | Robert Ian Lechler | ||
| Board | Stephanie Galantine-Heller | ||
| Board | Yael Gruenbaum Cohen | ||
| Board | Norbert Wolfgang Bischofberger | ||
| Owner (100%) | MiNA (Holdings) Limited | ||
| Auditor | EY Godkendt Revisionspartnerselskab | ||
| Auditor | Boreco Statsautoriseret Revisionspartnerselskab | ||
| Founder | MiNA (Holdings) Limited |
The CEOs' other companies
Troels Koch – 4 other companies
- Aqiventa ApS Opløst
- EXIQON A/S Fusioneret
- GEMINITAURUS INVEST ApS Fusioneret
- TUTO ApS Opløst
Address history (1 moves)
| c/o University of Aalborg, Frederikskaj 10B, 2., 2450 København SV | |
| Funkiavej 47, 2300 København S |
Other companies at the same address
- DEALOQ ApS Bankrupt
- Aqiventa ApS Opløst
Similar companies in København
- H. LUNDBECK A/S Valby
- GUNNAR KJEMS ApS København K
- Tetrapharm Therapeutics ApS København S
- Tetrapharm Bioengineering ApS København S
- Luvalis Pharma ApS Vanløse
- NeuroVersis Therapeutics ApS København K
- QuantumCell ApS København K
- Vautia Therapeutics ApS København K
- Corxel Pharmaceuticals Denmark ApS København V
- Dispersome IP ApS København Ø
- Maddox Pharma Swiss ApS København S
- Gefjon Pharma ApS København N
Questions and answers about MiNA Therapeutics Denmark ApS
Has MiNA Therapeutics Denmark ApS gone bankrupt?
No, MiNA Therapeutics Denmark ApS is not registered as bankrupt in the CVR register. Its status is: dissolved by declaration.
Who is the auditor of MiNA Therapeutics Denmark ApS?
MiNA Therapeutics Denmark ApS most recently used Boreco.
When was MiNA Therapeutics Denmark ApS founded?
MiNA Therapeutics Denmark ApS was founded on 15 June 2022.
What is the equity of MiNA Therapeutics Denmark ApS?
Equity was DKK 1.3m according to the annual report for the period ending 31 December 2024.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.